586 related articles for article (PubMed ID: 35140743)
1. Analysis of Pathogenic Pseudoexons Reveals Novel Mechanisms Driving Cryptic Splicing.
Keegan NP; Wilton SD; Fletcher S
Front Genet; 2021; 12():806946. PubMed ID: 35140743
[TBL] [Abstract][Full Text] [Related]
2. Pseudoexon activation in disease by non-splice site deep intronic sequence variation - wild type pseudoexons constitute high-risk sites in the human genome.
Petersen USS; Doktor TK; Andresen BS
Hum Mutat; 2022 Feb; 43(2):103-127. PubMed ID: 34837434
[TBL] [Abstract][Full Text] [Related]
3. Silencer elements as possible inhibitors of pseudoexon splicing.
Sironi M; Menozzi G; Riva L; Cagliani R; Comi GP; Bresolin N; Giorda R; Pozzoli U
Nucleic Acids Res; 2004; 32(5):1783-91. PubMed ID: 15034146
[TBL] [Abstract][Full Text] [Related]
4. Antisense Oligonucleotide Rescue of Deep-Intronic Variants Activating Pseudoexons in the 6-Pyruvoyl-Tetrahydropterin Synthase Gene.
Martínez-Pizarro A; Leal F; Holm LL; Doktor TK; Petersen USS; Bueno M; Thöny B; Pérez B; Andresen BS; Desviat LR
Nucleic Acid Ther; 2022 Oct; 32(5):378-390. PubMed ID: 35833796
[TBL] [Abstract][Full Text] [Related]
5. Multiple splicing defects in an intronic false exon.
Sun H; Chasin LA
Mol Cell Biol; 2000 Sep; 20(17):6414-25. PubMed ID: 10938119
[TBL] [Abstract][Full Text] [Related]
6. Disease-causing mutations improving the branch site and polypyrimidine tract: pseudoexon activation of LINE-2 and antisense Alu lacking the poly(T)-tail.
Meili D; Kralovicova J; Zagalak J; Bonafé L; Fiori L; Blau N; Thöny B; Vorechovsky I
Hum Mutat; 2009 May; 30(5):823-31. PubMed ID: 19280650
[TBL] [Abstract][Full Text] [Related]
7. Splicing Characteristics of Dystrophin Pseudoexons and Identification of a Novel Pathogenic Intronic Variant in the
Xie Z; Tang L; Xie Z; Sun C; Shuai H; Zhou C; Liu Y; Yu M; Zheng Y; Meng L; Zhang W; Leal SM; Wang Z; Schrauwen I; Yuan Y
Genes (Basel); 2020 Oct; 11(10):. PubMed ID: 33050418
[TBL] [Abstract][Full Text] [Related]
8. Background splicing as a predictor of aberrant splicing in genetic disease.
D A; Y L; R S; H D; E B; Rm W; I V; L C; N J D
RNA Biol; 2022; 19(1):256-265. PubMed ID: 35188075
[TBL] [Abstract][Full Text] [Related]
9. Detailed molecular characterization of a novel IDS exonic mutation associated with multiple pseudoexon activation.
Grodecká L; Kováčová T; Kramárek M; Seneca S; Stouffs K; De Laet C; Majer F; Kršjaková T; Hujová P; Hrnčířová K; Souček P; Lissens W; Buratti E; Freiberger T
J Mol Med (Berl); 2017 Mar; 95(3):299-309. PubMed ID: 27837218
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive characterisation of intronic mis-splicing mutations in human cancers.
Jung H; Lee KS; Choi JK
Oncogene; 2021 Feb; 40(7):1347-1361. PubMed ID: 33420369
[TBL] [Abstract][Full Text] [Related]
11. Splicing mutations in inherited retinal diseases.
Weisschuh N; Buena-Atienza E; Wissinger B
Prog Retin Eye Res; 2021 Jan; 80():100874. PubMed ID: 32553897
[TBL] [Abstract][Full Text] [Related]
12. Pseudoexons of the DMD Gene.
Keegan NP
J Neuromuscul Dis; 2020; 7(2):77-95. PubMed ID: 32176650
[TBL] [Abstract][Full Text] [Related]
13. DMD pseudoexon mutations: splicing efficiency, phenotype, and potential therapy.
Gurvich OL; Tuohy TM; Howard MT; Finkel RS; Medne L; Anderson CB; Weiss RB; Wilton SD; Flanigan KM
Ann Neurol; 2008 Jan; 63(1):81-9. PubMed ID: 18059005
[TBL] [Abstract][Full Text] [Related]
14. The intronic splicing code: multiple factors involved in ATM pseudoexon definition.
Dhir A; Buratti E; van Santen MA; Lührmann R; Baralle FE
EMBO J; 2010 Feb; 29(4):749-60. PubMed ID: 20094034
[TBL] [Abstract][Full Text] [Related]
15. The deep intronic c.903+469T>C mutation in the MTRR gene creates an SF2/ASF binding exonic splicing enhancer, which leads to pseudoexon activation and causes the cblE type of homocystinuria.
Homolova K; Zavadakova P; Doktor TK; Schroeder LD; Kozich V; Andresen BS
Hum Mutat; 2010 Apr; 31(4):437-44. PubMed ID: 20120036
[TBL] [Abstract][Full Text] [Related]
16. Role of Splicing Regulatory Elements and In Silico Tools Usage in the Identification of Deep Intronic Splicing Variants in Hereditary Breast/Ovarian Cancer Genes.
Moles-Fernández A; Domènech-Vivó J; Tenés A; Balmaña J; Diez O; Gutiérrez-Enríquez S
Cancers (Basel); 2021 Jul; 13(13):. PubMed ID: 34283047
[TBL] [Abstract][Full Text] [Related]
17. Systematic Computational Identification of Variants That Activate Exonic and Intronic Cryptic Splice Sites.
Lee M; Roos P; Sharma N; Atalar M; Evans TA; Pellicore MJ; Davis E; Lam AN; Stanley SE; Khalil SE; Solomon GM; Walker D; Raraigh KS; Vecchio-Pagan B; Armanios M; Cutting GR
Am J Hum Genet; 2017 May; 100(5):751-765. PubMed ID: 28475858
[TBL] [Abstract][Full Text] [Related]
18. Next-generation sequencing reveals deep intronic cryptic ABCC8 and HADH splicing founder mutations causing hyperinsulinism by pseudoexon activation.
Flanagan SE; Xie W; Caswell R; Damhuis A; Vianey-Saban C; Akcay T; Darendeliler F; Bas F; Guven A; Siklar Z; Ocal G; Berberoglu M; Murphy N; O'Sullivan M; Green A; Clayton PE; Banerjee I; Clayton PT; Hussain K; Weedon MN; Ellard S
Am J Hum Genet; 2013 Jan; 92(1):131-6. PubMed ID: 23273570
[TBL] [Abstract][Full Text] [Related]
19. Minigene Splicing Assays and Long-Read Sequencing to Unravel Pathogenic Deep-Intronic Variants in
Tamayo A; Núñez-Moreno G; Ruiz C; Plaisancie J; Damian A; Moya J; Chassaing N; Calvas P; Ayuso C; Minguez P; Corton M
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675087
[TBL] [Abstract][Full Text] [Related]
20. Identification of splice defects due to noncanonical splice site or deep-intronic variants in ABCA4.
Fadaie Z; Khan M; Del Pozo-Valero M; Cornelis SS; Ayuso C; Cremers FPM; Roosing S; The Abca Study Group
Hum Mutat; 2019 Dec; 40(12):2365-2376. PubMed ID: 31397521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]